|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/12/17 | Vernalis : AGM Statement | PU |
| 14/12/17 | Vernalis PLC: AGM Statement | MW |
| 13/12/17 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/12/17 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/12/17 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 66 | 05/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 01/11/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 01/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.65% | - | - | 0 | ||
| +0.99% | +1.78% | +5.07% | +16.49% | 49.47B | ||
| +3.71% | +9.40% | +486.14% | +579.98% | 43.97B | ||
| +5.60% | +10.21% | +20.85% | +81.78% | 39.6B | ||
| +2.70% | +1.57% | +32.71% | +9.07% | 39.29B | ||
| +2.21% | +6.75% | +20.20% | +54.40% | 32.43B | ||
| +2.23% | +4.71% | - | - | 16.84B | ||
| +0.97% | +2.35% | +35.99% | +124.45% | 16.49B | ||
| -0.11% | +2.41% | +5.03% | +20.47% | 14.01B | ||
| +0.75% | +15.04% | +79.84% | +29.70% | 12.77B | ||
| Average | +1.90% | +6.32% | +85.73% | +114.54% | 29.43B | |
| Weighted average by Cap. | +2.54% | +6.10% | +105.13% | +138.67% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
















